박영석 프로필 사진

박영석

PARK, YOUNG SUK

의과대학

의학과

Scopus

자료유형

발행연도

2007 ~ 2026
2007 2026

키워드

언어

전체 293건 중 1번부터 10번까지의 결과를 표시합니다.

2026
Article

Genomic Landscape of GNAQ and GNA11 Mutations in Metastatic Solid Tumors: A Real-World Data Analysis

  • 2026-07
  • JCO PRECISION ONCOLOGY
  • LIPPINCOTT WILLIAMS & WILKINS
Article

Contribution of atezolizumab (atezo) to the efficacy of the zanzalintinib (zanza) plus atezo combination in patients (pts) with previously treated metastatic colorectal cancer (mCRC): Evidence from the phase 3 STELLAR-303 trial.

  • Dauki, Anees
  • Yue, Mun Sang
  • Khosravan, Reza
  • He, Cixin
  • Saeed, Anwaar
  • ... Park, Young Suk
  • 외 5명
  • 2026-06-01
  • Journal of Clinical Oncology
  • LIPPINCOTT WILLIAMS & WILKINS
Article

Genomic landscape of ERBB3 alterations in 5,416 metastatic solid tumors: Real-world evidence regarding biomarker-agnostic ADC strategies

  • 2026-06-01
  • Journal of Clinical Oncology
  • LIPPINCOTT WILLIAMS & WILKINS
Article

Cold-spot driven local failure after stereotactic body radiation therapy for colorectal liver metastases

  • 2026-04-17
  • Frontiers in Oncology
  • FRONTIERS MEDIA SA
Article

Threshold Dose-Response Association Between Alcohol Consumption and Risk of Young-Onset Pancreatic Cancer: A Nationwide Korean Cohort Study of Young Adults Age 20-39 Years

  • 2026-03-20
  • Journal of Clinical Oncology
  • LIPPINCOTT WILLIAMS & WILKINS
Article

Prediabetes Remission and the Subsequent Risk of Pancreatic Cancer: A Nationwide Cohort Study

  • 2026-01
  • American Journal of Preventive Medicine
  • Elsevier Inc.
Article

Increased risk of young-onset pancreatic cancer among adults aged 20–39 years with overweight or obesity, but not underweight: A nationwide cohort study

  • 2026-01
  • European Journal of Cancer
  • Elsevier Ltd
Article

Molecular analysis to predict the clinical benefit of everolimus in gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs).

  • 2026-01
  • Journal of Clinical Oncology
  • LIPPINCOTT WILLIAMS & WILKINS
2025
Article

Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial

  • Hecht, J. Randolph
  • Park, Young Suk
  • Tabernero, Josep
  • Lee, Myung-Ah
  • Lee, Soohyeon
  • 외 14명
  • 2025-11-15
  • The Lancet
  • ELSEVIER SCIENCE INC
1